Endocrinology

2017/10/07MEDICAL UPDATE

Diabetes drug shows potential in treating Parkinson’s Disease

Author: Bruce Sylvester Exenatide, a drug used to treat diabetes, could have disease-modifying potential in the treatment of Parkinson’s disease, researchers reported on August 3, 2017 in The Lancet.

READ MORE

2016/08/09MEDICAL UPDATE

Diabetes risk lowered by eating healthy fats instead of carbs or saturated fats

by Bruce Sylvester: Results from a meta-analysis of relevant studies suggest that consumption of unsaturated fats instead of either saturated fats or carbohydrates could help  prevent and manage  type 2 diabetes.

READ MORE

2016/07/06MEDICAL UPDATE

Diabetes drug liraglutide shows “across-the-board” cardiovascular benefits

by Bruce Sylvester: Researchers have identified an across-the-board cardiovascular benefit for patients treated with a diabetes drug, liraglutide, with decreases reported in overall risk of heart attack, stroke, or cardiovascular death.

READ MORE

2015/07/28MEDICAL UPDATE

Diabetes-related dementia linked to other complications

by Bruce Sylvester: Persons with high rates of diabetes-related complications appear to  be more likely to develop dementia as they get older than persons with fewer diabetes-related complications, South Korean researchers reported on July 9, 2015 in the  Journal of Clinical Endocrinology & Metabolism.

READ MORE

2014/11/28MEDICAL UPDATE

Bariatric surgery appears to significantly lower the risk of type 2 diabetes

by Bruce Sylvester: Compared with standard care, bariatric surgery appears to lower the risk of developing type 2 diabetes by about 80% among obese persons, researchers reported on Nov. 2, 2014 in The Lancet Diabetes & Endocrinology.

READ MORE

2014/07/07MEDICAL UPDATE

ADA 2014 Report: More evidence for Canola Oil

Adding canola oil to the diet improved glycemic control and reduced cardiovascular risk in type 2 diabetes in one study, while an overall healthier diet reduced risk of developing diabetes in another.

READ MORE

2014/07/04MEDICAL UPDATE

ADA 2014 Report: Insulin not associated with increased Cancer risk

Despite some concerns to the contrary, the use of insulin glargine (Lantus) is not associated with an increased risk of any cancer in people with diabetes or prediabetes, according to a substudy of the prospective Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial.

READ MORE

2014/07/04MEDICAL UPDATE

ADA 2014 Report: Hope for artificial Pancreas

A bihormonal "artificial pancreas" improved glycemic control and led to less hypoglycemia in type 1 diabetes patients, researchers reported here.

READ MORE

2014/07/03MEDICAL UPDATE

Update – Safe handling of insulin OR Avoiding errors with insulin

by Christine Clark - Insulin ranks among the top 10 ‘high-alert’ or high-risk medicines worldwide. (ref  NPSA/2011/PSA003) It is also been an important cause of hospital admissions, mainly as a consequence of severe hypoglycaemia. (ref  NPSA/2011/PSA003)  As the prevalence of diabetes in Europe and the number of insulin products available both continue to increase it is important for all those involved in the prescribing and administration of insulin to be aware of the risks and the necessary safety measures.

READ MORE

2014/07/03MEDICAL UPDATE

ADA 2014 Report: National guidelines for lipids and blood pressure

National guidelines for lipids and blood pressure are likely to be a focus of attention at this year's meeting of the American Diabetes Association.

READ MORE